Literature DB >> 14698151

Adenine derived inhibitors of the molecular chaperone HSP90-SAR explained through multiple X-ray structures.

Brian Dymock1, Xavier Barril, Mandy Beswick, Adam Collier, Nicholas Davies, Martin Drysdale, Alexandra Fink, Christophe Fromont, Roderick E Hubbard, Andrew Massey, Allan Surgenor, Lisa Wright.   

Abstract

Multiple co-crystal structures of an adenine-based series of inhibitors bound to the molecular chaperone Hsp90 have been determined. These structures explain the observed SAR for previously described compounds and new compounds, which possess up to 8-fold improved potency against the isolated enzyme. Anti-tumour cell potency and mechanism of action data is also described for the most potent compounds. These data should enable the design of more potent Hsp90 inhibitors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14698151     DOI: 10.1016/j.bmcl.2003.11.011

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

1.  Microwave-assisted one step synthesis of 8-arylmethyl-9H-purin-6-amines.

Authors:  Hui Tao; Yanlong Kang; Tony Taldone; Gabriela Chiosis
Journal:  Bioorg Med Chem Lett       Date:  2008-11-20       Impact factor: 2.823

2.  The multiple roles of computational chemistry in fragment-based drug design.

Authors:  Richard Law; Oliver Barker; John J Barker; Thomas Hesterkamp; Robert Godemann; Ole Andersen; Tara Fryatt; Steve Courtney; Dave Hallett; Mark Whittaker
Journal:  J Comput Aided Mol Des       Date:  2009-06-17       Impact factor: 3.686

Review 3.  The G protein α chaperone Ric-8 as a potential therapeutic target.

Authors:  Makaía M Papasergi; Bharti R Patel; Gregory G Tall
Journal:  Mol Pharmacol       Date:  2014-10-15       Impact factor: 4.436

4.  Computational polypharmacology analysis of the heat shock protein 90 interactome.

Authors:  Andrew Anighoro; Dagmar Stumpfe; Kathrin Heikamp; Kristin Beebe; Leonard M Neckers; Jürgen Bajorath; Giulio Rastelli
Journal:  J Chem Inf Model       Date:  2015-02-23       Impact factor: 4.956

Review 5.  Purine-scaffold Hsp90 inhibitors.

Authors:  Tony Taldone; Gabriela Chiosis
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

Review 6.  Targeting multiple signal transduction pathways through inhibition of Hsp90.

Authors:  Hong Zhang; Francis Burrows
Journal:  J Mol Med (Berl)       Date:  2004-05-27       Impact factor: 4.599

7.  Structural determination of three different series of compounds as Hsp90 inhibitors using 3D-QSAR modeling, molecular docking and molecular dynamics methods.

Authors:  Jianling Liu; Fangfang Wang; Zhi Ma; Xia Wang; Yonghua Wang
Journal:  Int J Mol Sci       Date:  2011-01-30       Impact factor: 5.923

8.  Scoring functions and enrichment: a case study on Hsp90.

Authors:  Chrysi Konstantinou-Kirtay; John B O Mitchell; James A Lumley
Journal:  BMC Bioinformatics       Date:  2007-01-26       Impact factor: 3.169

Review 9.  Therapeutic and diagnostic implications of Hsp90 activation.

Authors:  Adeela Kamal; Marcus F Boehm; Francis J Burrows
Journal:  Trends Mol Med       Date:  2004-06       Impact factor: 11.951

10.  Discovery of Novel Allopurinol Derivatives with Anticancer Activity and Attenuated Xanthine Oxidase Inhibition.

Authors:  Yong Li; Ting-Ting Cao; Shanchun Guo; Qiu Zhong; Cai-Hu Li; Ying Li; Lin Dong; Shilong Zheng; Guangdi Wang; Shu-Fan Yin
Journal:  Molecules       Date:  2016-06-20       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.